Biodesix to Participate in Upcoming Investor Conferences
Biodesix, Inc. announced its participation in three upcoming investor conferences in September 2026. The company reported Q2 2026 revenue of $26.9 million, representing 34% growth, with an 82% gross margin. Biodesix maintained its FY 2026 revenue guidance of $108-114 million, reflecting 25% growth expectations.